Amit K. Sachdev (IM'90) is Executive Vice President, Chief Patient Officer & Chief of Staff to the CEO at Vertex Pharmaceuticals, where he has served over the past fourteen years in numerous executive leadership roles spanning the business as an executive officer and member of the Executive Committee, including regulatory affairs as Chief Regulatory Officer, global market access and pricing, health economics and outcomes research, international commercial operations, alliance management, public affairs, and corporate communications.
During this time, the Company experienced ten-fold growth and successfully developed and commercialized five novel breakthrough medicines for patients with serious liver disease and for patients with a life-threatening lung disease called cystic fibrosis. Today, Vertex is one of the world’s leading global biotechnology companies with its headquarters in Boston, Massachusetts.
Amit also serves as an independent board member at Eiger Biopharmaceuticals in Palo, Alto, CA where he chairs the Board Nominations and Governance Committee. He also serves on several non-profit and philanthropic boards, including MassBIO, a biotechnology innovation association, Imagine and Answer, a charity group focused on supporting research into rare forms of low-grade pediatric brain cancer and Team Impact, a non-profit helping children tackle the emotional trauma and social isolation experienced by children facing serious chronic illness, where he also serves as Chair of the Diversity and Inclusion Committee. Since 2017 he has also been a member of the Board of Advisors for Stanford University’s Center for Longevity Studies.